Pfizer completes sale of animal health biz for Rs 471.60 cr
Top Stories
- Former Ranji player held, Sreesanth and others to be produced in court today
- Li Keqiang pitches for more Chinese investments as he backs trade balance
- All eyes on Narendra Modi as BJP set to discuss strategy for Lok Sabha polls
- SC agrees to hear PIL to stay IPL matches due to spot-fixing
- Monstrous tornado rips through US city of Oklahoma, 90 dead
Drug major Pfizer Ltd today said it has completed the sale of its subsidiary PAPPL to Pfizer Animal Health India Ltd (PAHIL), which is owned by US-based Pfizer Inc, for Rs 471.60 crore.
"..transaction of the sale of the entire equity stake by the company and its nominees in PAPPL (Pfizer Animal Pharma Pvt Ltd) to PAHIL has been completed and the company has received the consideration amount of Rs 471.60 crore," Pfizer said in a filing to BSE.
Pfizer Ltd had said earlier that the development is part of a global internal re-organisation taken up by its parent, Pfizer Inc, in July 2011 under which it was reviewing strategic alternatives for its global animal health business.
Pfizer's animal health business has presence primarily in the large animal health and poultry market segments and also includes rendering of marketing services.
Pfizer scrip closed at Rs 1,135.35 on the BSE, down 1.43 per cent from its previous close.
Editors’ Pick
- 'Sophisticated' Indian cyberattacks targeted Pak military sites: Report
- Talkative Li quoted Weber, Hegel, Jobs, said PM is large-hearted
- Bihar food corp ends up with chaff as rice worth Rs 535 cr vanishes from mills
- In 7 lucrative minutes on May 9, Sreesanth bowled 6 balls, bookie made Rs 2.5 cr
- India and China ask border envoys to work on more steps
- Former Ranji player among 3 more held
- Rajasthan Royals to file FIR against tainted trio
- Family of theft accused allege police torture
- IVF breakthrough can triple number of births: Scientists
- After Khalid’s death, Muslim leaders want govt to make Nimesh panel report public
- Meteoroid impact triggers bright flash on the moon
- Cobrapost sting: NABARD chief gives clean chit to co-operative banks


No interim relief to Sterlite Industries over gas leakage: National Green Tribunal
Ranbaxy Laboratories Q1 net profit dips 90% to Rs 126 cr
GlaxoSmithKline Pharma Q1 net profit up 37.52%
Air India to slash free baggage allowance, charge more



















